Product image of Neomicina Labesfal (Neomycin) supplied by GNH India

Neomicina Labesfal

Active Ingredient:
Neomycin
Origin:
EU

Neomicina Labesfal (Neomycin)

Neomycin, the active ingredient in Neomicina Labesfal, is an aminoglycoside antibiotic presented as an oral formulation for systemic use. Originating from the European Union market, it targets intestinal infections caused by susceptible Gram‑negative and some Gram‑positive bacteria, and is used in both adult and pediatric patients requiring localized gut activity.

GNH India supplies Neomicina Labesfal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory adherence, and reliable and timely distribution across multiple markets.

Manufacturer / TM Owner

Labesfal Laboratorios Almiro, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Neomicina Labesfal (neomycin) is an aminoglycoside antibiotic used to manage bacterial infections of the gastrointestinal tract.
  • Intestinal bacterial infection: eradicates susceptible pathogens causing diarrhea and abdominal discomfort.
  • Pre‑operative bowel decontamination: reduces colonic bacterial load before abdominal or colorectal surgery.
  • Hepatic encephalopathy prophylaxis: lowers ammonia‑producing gut flora to help prevent neuro‑cognitive episodes.

How It Works

  • Neomycin binds to the bacterial 30S ribosomal subunit, causing misreading of mRNA and inhibition of protein synthesis. This action is bactericidal against susceptible aerobic Gram‑negative organisms and some Gram‑positive strains, leading to disruption of essential cellular functions and bacterial cell death within the intestinal lumen.

Side Effects

Neomicina Labesfal may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Vomiting: occasional emesis after oral intake.
  • Diarrhea: loose stools during therapy.
  • Abdominal pain: cramping or discomfort.
  • Taste disturbance: altered perception of flavors.
  • Rash: mild skin irritation or erythema.

Serious or Rare Side Effects

  • Ototoxicity: hearing loss or balance disturbances, especially with prolonged use.
  • Nephrotoxicity: impaired kidney function, indicated by rising serum creatinine.
  • Severe allergic reaction: anaphylaxis, angioedema, or bronchospasm.
  • Clostridioides difficile infection: severe colitis following disruption of normal flora.
  • Persistent vomiting: leading to dehydration.
  • Hematologic abnormalities: rare blood cell count changes.

Precautions & Warnings

  • Before prescribing Neomicina Labesfal, clinicians should consider patient‑specific factors and monitor for potential complications.
  • Renal impairment: assess kidney function and adjust therapy as needed.
  • Hearing loss risk: avoid in patients with pre‑existing ototoxicity or concurrent ototoxic drugs.
  • Pregnancy: use only when benefits outweigh potential fetal risks.
  • Allergy: discontinue immediately if hypersensitivity signs appear.
  • Drug interactions: review concomitant nephrotoxic or ototoxic agents.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Neomicina Labesfal can interact with other medicines, altering safety or efficacy.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics (e.g., gentamicin): additive nephrotoxicity and ototoxicity.
  • Loop diuretics (e.g., furosemide): increased risk of ototoxic effects.
  • NSAIDs (e.g., ibuprofen): heightened potential for renal impairment.

Moderate Interactions (Monitor Closely)

  • Vancomycin: combined risk of kidney injury.
  • Cyclosporine: may amplify nephrotoxic effects.
  • Radiographic contrast media: monitor renal function during concurrent use.

Frequently Asked Questions

Neomicina Labesfal contains neomycin, an aminoglycoside antibiotic that is used primarily to treat intestinal bacterial infections. It is also employed for pre‑operative bowel decontamination and as part of prophylaxis for hepatic encephalopathy by reducing ammonia‑producing gut flora.

Neomycin exerts its antibacterial effect by binding to the 30S subunit of bacterial ribosomes. This binding disrupts the accurate reading of messenger RNA, leading to faulty protein synthesis and ultimately causing bacterial cell death, especially against susceptible Gram‑negative organisms in the gastrointestinal tract.

The specific dose of Neomicina Labesfal is determined by the prescribing clinician based on the patient’s age, weight, severity of infection, and renal function. Healthcare providers set the regimen according to current clinical guidelines and individual patient needs.

Safety data for neomycin in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neomicina Labesfal (neomycin) is an aminoglycoside, differing from broad‑spectrum agents such as ciprofloxacin or metronidazole. Its primary advantage is limited systemic absorption, making it useful for targeting gut flora with minimal systemic exposure, whereas other classes may have broader tissue distribution and different resistance profiles.

Neomicina Labesfal should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

The medication is taken orally, usually as a tablet or oral suspension, according to the prescriber’s instructions. It should be swallowed with water and may be taken with or without food, depending on the specific formulation and clinical guidance.

The most serious adverse effects include ototoxicity, which can cause irreversible hearing loss or balance problems, and nephrotoxicity, leading to impaired kidney function. Severe allergic reactions such as anaphylaxis and Clostridioides difficile‑associated colitis are also rare but critical concerns.

Patients with known hypersensitivity to neomycin or other aminoglycosides should avoid the product. It is also contraindicated in individuals with pre‑existing severe renal impairment or hearing loss, and it should be used with caution in pregnant or lactating women when no safer alternative exists.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Neomycin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT